We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDRX
7751
Biodexa Pharmaceuticals
BDRX
$1.35M
$8.96K ﹤0.01%
8
+6
+300% +$7.86K
FPH icon
7752
Five Point Holdings
FPH
$379M
$8.95K ﹤0.01%
3,056
+2,282
+295% +$7.04K
RVNU icon
7753
Xtrackers Municipal Infrastructure Revenue Bond ETF
RVNU
$143M
$8.95K ﹤0.01%
351
+276
+368% +$7K
ORGN
7754
DELISTED
Origin Materials
ORGN
$8.91K ﹤0.01%
330
-4,345
-93% -$116K
GERM
7755
DELISTED
Amplify Treatments, Testing and Advancements ETF
GERM
$8.87K ﹤0.01%
487
-501
-51% -$9.16K
JPRE icon
7756
JPMorgan Realty Income ETF
JPRE
$487M
$8.86K ﹤0.01%
201
+158
+367% +$6.75K
PLBY icon
7757
Playboy Inc
PLBY
$141M
$8.85K ﹤0.01%
11,388
-13,006
-53% -$12.1K
SPUU icon
7758
Direxion Daily S&P 500 Bull 2X ETF
SPUU
$281M
$8.82K ﹤0.01%
+67
New +$8.2K
BTCS icon
7759
BTCS Inc
BTCS
$53.3M
$8.82K ﹤0.01%
6,390
+6,388
+319,400% +$9.75K
MGX icon
7760
Metagenomi Therapeutics
MGX
$45.6M
$8.8K ﹤0.01%
2,158
+478
+28% +$3.28K
ALLR
7761
Allarity Therapeutics
ALLR
$20.8M
$8.78K ﹤0.01%
1,374
+1,319
+2,398% +$51.8K
PRTC
7762
DELISTED
PureTech Health
PRTC
$8.78K ﹤0.01%
351
+331
+1,655% +$9.27K
ASBP
7763
Aspire Biopharma
ASBP
$9.12M
$8.75K ﹤0.01%
+1
New +$13.6K
PPYA
7764
DELISTED
Papaya Growth Opportunity Corp. I Class A Common Stock
PPYA
$8.75K ﹤0.01%
+792
New +$8.83K
FLKR icon
7765
Franklin FTSE South Korea ETF
FLKR
$1.42B
$8.75K ﹤0.01%
+400
New +$8.93K
SXTP icon
7766
60 Degrees Pharmaceuticals
SXTP
$3.27M
$8.72K ﹤0.01%
+144
New +$9.14K
CWEB icon
7767
Direxion Daily CSI China Internet Index Bull 2X ETF
CWEB
$261M
$8.71K ﹤0.01%
287
+260
+963% +$9.08K
RNTX
7768
Rein Therapeutics
RNTX
$65.3M
$8.71K ﹤0.01%
3,145
+3,052
+3,282% +$12.5K
GENK icon
7769
GEN Restaurant Group
GENK
$10.6M
$8.7K ﹤0.01%
960
-3,165
-77% -$33.2K
YRD
7770
Yiren Digital
YRD
$101M
$8.69K ﹤0.01%
1,919
-3,671
-66% -$18K
YDKG
7771
Yueda Digital Holding
YDKG
$5.92M
$8.69K ﹤0.01%
+80
New +$9.67K
SCKT icon
7772
Socket Mobile
SCKT
$3.39M
$8.68K ﹤0.01%
8,036
+6,927
+625% +$8.11K
HURC icon
7773
Hurco Companies Inc
HURC
$139M
$8.67K ﹤0.01%
568
-331
-37% -$5.96K
PSIL icon
7774
AdvisorShares Psychedelics ETF
PSIL
$49.6M
$8.65K ﹤0.01%
+886
New +$10.9K
JULH icon
7775
Innovator Premium Income 20 Barrier ETF July
JULH
$16.3M
$8.65K ﹤0.01%
349
+313
+869% +$7.85K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.